The Breakthrough They Couldn’t Buy – the Insider’s Point of View
Vera Czerny interviews Dr. Dan Hartley, who worked for the pharmaceutical company that tried to purchase the technology for stabilizing the Redox Signaling Molecules in the patented product, Asea. They discuss Dr. Hartley’s history and the early beginnings of the company and also the products.
ASEA’s Big Decision: The Truth Behind the Pharma Buyout & Redox Breakthrough
Danielle Matthews interviews Dr. Dan Hartley, who worked for the pharmaceutical company that tried to purchase the technology for stabilizing the Redox Signaling Molecules in the patented product, Asea. They discuss the early beginnings of the company and also the products.